Status:

COMPLETED

Novel Treatment for Diastolic Heart Failure in Women

Lead Sponsor:

Baylor College of Medicine

Conditions:

Heart Failure

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironola...

Detailed Description

Subjects with diastolic heart failure defined based on clinical symptoms, echocardiography diastology parameters and brain natriuretic peptide level will be randomized in a 1:1 fashion to either place...

Eligibility Criteria

Inclusion

  • Women who are 18 years of age or older.
  • Women with clinical heart failure for \> 2 months.
  • Women with left ventricular ejection fraction \> 50% within 2 months of screening.
  • Women with New York Heart Association class II or III heart failure symptoms.
  • Brain Natriuretic Peptide \> 62 pg/ml within 2 months of screening.
  • Patient on angiotensin converting enzyme inhibitor or angiotensin receptor blocker therapy for at least 1 month.
  • Blood Pressure no more than 150/95.
  • Patient able to walk more than 50 meters at the time of enrollment.
  • Signed informed consent.

Exclusion

  • Current treatment with spironolactone.
  • Severe hepatic impairment.
  • Creatinine \> 2.5 mg/dl
  • Potassium \> 5.0 mEq/L
  • Intolerance to spironolactone in the past.
  • Significant valvular heart disease, pericardial disease, or severe chronic lung disease with cor pulmonale.
  • Unstable angina or myocardial infarction within the past 4 weeks.
  • Severe peripheral vascular disease or other physical conditions that would limit the walking distance.
  • Pregnant or lactating females.
  • Participation in any other drug trial within 30 days prior to randomization.
  • Inability to provide informed consent.

Key Trial Info

Start Date :

July 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00206232

Start Date

July 1 2004

End Date

July 1 2010

Last Update

February 18 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baylor College of Medicine Heart Clinic

Houston, Texas, United States, 77030

Novel Treatment for Diastolic Heart Failure in Women | DecenTrialz